Diabetes drug tested as potential breakthrough for opioid addiction

NCT ID NCT06651177

Summary

This study is testing whether adding tirzepatide, a medication currently used for diabetes and weight loss, to standard buprenorphine treatment helps people with opioid addiction. Researchers will enroll 310 adults who recently started buprenorphine treatment and randomly assign them to receive either tirzepatide or a placebo injection weekly for six months. The main goals are to see if the combination helps people stay in treatment longer, reduces opioid and other drug use, and improves sleep quality.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gateway Community Services

    RECRUITING

    Jacksonville, Florida, 32204, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Healthy Minds/Chestnut Ridge

    RECRUITING

    Morgantown, West Virginia, 26505, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • IBIS Behavioral Health

    NOT_YET_RECRUITING

    Tampa, Florida, 33605, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Marshall Health

    RECRUITING

    Huntington, West Virginia, 25701, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Prisma Health

    RECRUITING

    Greenville, South Carolina, 29605, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ruth M. Rothstein CORE Center

    RECRUITING

    Chicago, Illinois, 60612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tarzana Treatment Centers

    NOT_YET_RECRUITING

    Tarzana, California, 91356, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • The Gibson Center for Behavioral Change

    RECRUITING

    Cape Girardeau, Missouri, 63703, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Utah

    RECRUITING

    Salt Lake City, Utah, 84108, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.